Close Menu

In this week's Science, researchers at Caltech and MIT report "a general mechanism for network-dosage compensation in gene circuits," which they've developed using the galactose network as a model. Specifically, the team "combinatorially deleted one of the two copies of its four regulatory genes and found that network activity was robust to the change in network dosage," they write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.